创业3年，第一款药就卖了70亿，黄超兰太强了
7月11日，她所创立的昱言科技，与法国药企益普生达成合作，昱言科技将一款原创新药——ADC（抗体-药物偶联物）药物 FS001在全球范围内的开发、制造和商业化的独家权利许可给益普生，潜在总交易额高达10.3亿美元（约70亿人民币）。
不到一年涨1123%，1款好药足以改命，SMMT是什么来头？
过去一周，Summit成为当之无愧的明星公司，股价涨幅达到了160%，市值已经突破了230亿美元。作为对比，百济神州在美股的市值约为210亿美元左右。尽管Summit尚未有产品上市，但其市值却超过了这位创新领域的领头羊。
一周大涨160%，1款好药足以改命！Summit Therapeutics(SMMT.US)是什么来头？
Summit Therapeutics及其合作伙伴宣布，他们在名为HARMONi-2的3期试验中取得了积极成果。这项特殊的后期研究比较了单药ivonescimab与单药疗法Keytruda治疗PD-L1阳性的非小细胞肺癌 ...
Business Insider3d
UBS Keeps Their Hold Rating on BioNTech SE (BNTX)
UBS analyst Eliana Merle maintained a Hold rating on BioNTech SE (BNTX – Research Report) today and set a price target of $131.00. The company’s shares opened today at $121.40. According to ...
pharmaphorum2d
BioNTech cancer vaccine hits the spot in melanoma
mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...
pharmaphorum4d
Pfizer, BioNTech submit to FDA for Covid vaccine in under 5s
If this EUA application is authorised, children 6 months to under 5 years of age would receive a primary series consisting of two 3-µg doses of the original Pfizer/BioNTech COVID-19 Vaccine ...
央视网6d
国际观察｜日铁收购美钢受阻凸显美国政治因素对市场的干扰
日本媒体报道，日本钢铁巨头日本制铁公司（简称日铁）高管日前赴美与美国高级官员会面，以挽救日铁收购美国钢铁公司（简称美钢）的计划。此前，有消息称，美国总统拜登将以“国家安全 ...
Yahoo Finance6d
BioNTech SE (BNTX)
After hours: 16 September at 19:44 GMT-4 ...